DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» TIGIT
TIGIT
IL-15 Stimulation with TIGIT Blockade Reverses CD155-Mediated NK Cell
CD226 T Cells Expressing the Receptors TIGIT and Divergent Phenotypes of Human Regulatory
TIGIT Poster SITC 2018 V.2
Cell Function the TIGIT/CD226 Axis Regulates Human T
Antibody Engineers Seek Optimal Drug Targeting TIGIT Checkpoint
TIGIT-Fc Promotes Antitumour Immunity
IL-12 Family Cytokines in Cancer and Immunotherapy
Immune Checkpoint Molecules in Natural Killer Cells As Potential Targets for Cancer Immunotherapy
TIGIT/CD155 Blockade Bioassay, Propagation Model Instructions for Use of Product J2092
TIGIT Blockade: a Multipronged Approach to Target the HIV Reservoir
Human TIGIT on Porcine Aortic Endothelial Cells Suppresses
Inhibitory Functions Cutting Edge: TIGIT Has T Cell-Intrinsic
TIGIT-Fc Promote Immune Tolerance at the Feto-Maternal Interface
CD226 Opposes TIGIT to Disrupt Tregs in Melanoma
T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-Cell Receptor Signaling
PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes
TIGIT Enhances Antigen-Specific Th2 Recall Responses and Allergic Disease Evangelia Kourepini, Nikolaos Paschalidis, Davina C
TIGIT+ Itregs Elicited by Human Regulatory Macrophages Control T Cell Immunity
Top View
Detection of Immune Checkpoint Receptors &Ndash
Therapeutic Targeting of Checkpoint Receptors Within the DNAM1 Axis
Expression of TIGIT/CD155 and Correlations with Clinical Pathological Features in Human Hepatocellular Carcinoma
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
CD155: a Multi-Functional Molecule in Tumor Progression
Natural Killer Cells: a TACTILE Restraint
TIGIT/CD155 Blockade Bioassay Instructions for Use of Products J2201, J2205
CD155 Immunoregulation As a Target for Natural Killer Cell Immunotherapy in Glioblastoma Kyle B
Therapeutic Targeting of Checkpoint Receptors Within the DNAM-1 Axis
The Interaction of TIGIT with PVR and PVRL2 Inhibits Human NK Cell Cytotoxicity
Cellular Immunology TIGIT Expression Is Upregulated in T Cells And
TIGIT Expression Is Associated with T-Cell Suppression and Exhaustion and Predicts 2 Clinical Outcome and Anti-PD-1 Response in Follicular Lymphoma
TIGIT Is Upregulated by HIV-1 Infection and Marks a Highly Functional Adaptive and Mature Subset of Natural Killer Cells
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Review Article Immune Checkpoint Targeting TIGIT in Hepatocellular Carcinoma
TIGIT Negatively Regulates Inflammation by Altering
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid